These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

743 related items for PubMed ID: 17950511

  • 1. The inhibitory effect of tannic acid on cytochrome P450 enzymes and NADPH-CYP reductase in rat and human liver microsomes.
    Yao HT, Chang YW, Lan SJ, Yeh TK.
    Food Chem Toxicol; 2008 Feb; 46(2):645-53. PubMed ID: 17950511
    [Abstract] [Full Text] [Related]

  • 2. Non-specific inhibition of human cytochrome P450-catalyzed reactions by hemin.
    Kim EY, Kim JS, Kim MY, Koh WS, Guengerich FP, Yun CH.
    Toxicol Lett; 2004 Nov 02; 153(2):239-46. PubMed ID: 15451555
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of human cytochrome P450 isoforms and NADPH-CYP reductase in vitro by 15 herbal medicines, including Epimedii herba.
    Liu KH, Kim MJ, Jeon BH, Shon JH, Cha IJ, Cho KH, Lee SS, Shin JG.
    J Clin Pharm Ther; 2006 Feb 02; 31(1):83-91. PubMed ID: 16476124
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of cytochrome P450 activities by oleanolic acid and ursolic acid in human liver microsomes.
    Kim KA, Lee JS, Park HJ, Kim JW, Kim CJ, Shim IS, Kim NJ, Han SM, Lim S.
    Life Sci; 2004 Apr 16; 74(22):2769-79. PubMed ID: 15043991
    [Abstract] [Full Text] [Related]

  • 5. Characterization of hepatic drug-metabolizing activities of Bama miniature pigs (Sus scrofa domestica): comparison with human enzyme analogs.
    Li J, Liu Y, Zhang JW, Wei H, Yang L.
    Comp Med; 2006 Aug 16; 56(4):286-90. PubMed ID: 16941956
    [Abstract] [Full Text] [Related]

  • 6. Resveratrol is a selective human cytochrome P450 1A1 inhibitor.
    Chun YJ, Kim MY, Guengerich FP.
    Biochem Biophys Res Commun; 1999 Aug 19; 262(1):20-4. PubMed ID: 10448061
    [Abstract] [Full Text] [Related]

  • 7. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
    Mani C, Gelboin HV, Park SS, Pearce R, Parkinson A, Kupfer D.
    Drug Metab Dispos; 1993 Aug 19; 21(4):645-56. PubMed ID: 8104124
    [Abstract] [Full Text] [Related]

  • 8. In vitro metabolism of fipronil by human and rat cytochrome P450 and its interactions with testosterone and diazepam.
    Tang J, Amin Usmani K, Hodgson E, Rose RL.
    Chem Biol Interact; 2004 Apr 15; 147(3):319-29. PubMed ID: 15135087
    [Abstract] [Full Text] [Related]

  • 9. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
    Foroozesh M, Primrose G, Guo Z, Bell LC, Alworth WL, Guengerich FP.
    Chem Res Toxicol; 1997 Jan 15; 10(1):91-102. PubMed ID: 9074808
    [Abstract] [Full Text] [Related]

  • 10. Effects of freezing, thawing, and storing human liver microsomes on cytochrome P450 activity.
    Pearce RE, McIntyre CJ, Madan A, Sanzgiri U, Draper AJ, Bullock PL, Cook DC, Burton LA, Latham J, Nevins C, Parkinson A.
    Arch Biochem Biophys; 1996 Jul 15; 331(2):145-69. PubMed ID: 8660694
    [Abstract] [Full Text] [Related]

  • 11. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes.
    Danie WA, Syrek M, Ryłko Z, Wójcikowski J.
    Pol J Pharmacol; 2001 Jul 15; 53(4):351-7. PubMed ID: 11990081
    [Abstract] [Full Text] [Related]

  • 12. Differential inhibition of rat and human hepatic cytochrome P450 by Andrographis paniculata extract and andrographolide.
    Pekthong D, Martin H, Abadie C, Bonet A, Heyd B, Mantion G, Richert L.
    J Ethnopharmacol; 2008 Feb 12; 115(3):432-40. PubMed ID: 18053665
    [Abstract] [Full Text] [Related]

  • 13. Inhibitory effects of azelastine and its metabolites on drug oxidation catalyzed by human cytochrome P-450 enzymes.
    Nakajima M, Ohyama K, Nakamura S, Shimada N, Yamazaki H, Yokoi T.
    Drug Metab Dispos; 1999 Jul 12; 27(7):792-7. PubMed ID: 10383922
    [Abstract] [Full Text] [Related]

  • 14. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
    Eagling VA, Tjia JF, Back DJ.
    Br J Clin Pharmacol; 1998 Feb 12; 45(2):107-14. PubMed ID: 9491822
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Suppressive effect of the ethanolic extract of adlay bran on cytochrome P-450 enzymes in rat liver and lungs.
    Yao HT, Lin JH, Chiang MT, Chiang W, Luo MN, Lii CK.
    J Agric Food Chem; 2011 Apr 27; 59(8):4306-14. PubMed ID: 21395288
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. An inhibition study of beauvericin on human and rat cytochrome P450 enzymes and its pharmacokinetics in rats.
    Mei L, Zhang L, Dai R.
    J Enzyme Inhib Med Chem; 2009 Jun 27; 24(3):753-62. PubMed ID: 18956271
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.